In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants

References

• Thombre AG. Assessment of the feasibility of oral controlled release in an exploratory development setting. Drug Discovery Today. 2005;10:1159–1166.
   PubMed Web of Science ®Google Scholar
• Chen J, Pan H, Ye T, et al. Recent aspects of osmotic pump systems: functionalization, clinical use and advanced imaging technology. Curr Drug Metab. 2015;17:279.
   Web of Science ®Google Scholar
• Timmins P, Desai D, Chen W, et al. Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets. Ther Deliv. 2016;7:553–572.
   PubMed Web of Science ®Google Scholar
• Shojaee S, Nokhodchi A, Maniruzzaman M. Evaluation of the drug solubility and rush ageing on drug release performance of various model drugs from the modified release polyethylene oxide matrix tablets. Drug Deliv Transl Res. 2017;7:111–124.
   PubMed Web of Science ®Google Scholar
• Yarce CJ, Echeverri JD, Palacio MA, et al. Relationship between surface properties and in vitro drug release from compressed matrix containing polymeric materials with different hydrophobicity degrees. Pharmaceuticals. 2017;10:15. doi:10.3390/ph10010015
   Web of Science ®Google Scholar
• Košir D, Ojsteršek T, Baumgartner S, et al. A study of critical functionality-related characteristics of HPMC for sustained-release tablets. Pharm Dev Technol. 2016 [Dec 23];[1–9]. doi: 10.1080/10837450.2016.1264417
   PubMed Web of Science ®Google Scholar
• Zhou D, Law D, Reynolds J, et al. Understanding and managing the impact of HPMC variability on drug release from controlled release formulations. J Pharm Sci. 2014;103(6):1664–1672.
   Google Scholar
• Maggi L, Bruni R, Conte U. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms. Int J Pharm. 2000;195:229–238.
   PubMed Web of Science ®Google Scholar
• Kim CJ. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets. Drug Dev Ind Pharm. 1998;24:645.
   PubMed Web of Science ®Google Scholar
• Shojaee S, Kaialy W, Cumming KI, et al. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type. Pharm Dev Technol. 2016;21:189–195.
   PubMed Web of Science ®Google Scholar
• Zhang F, Meng F, Lubach J, et al. Properties and mechanisms of drug release from matrix tablets containing poly(ethylene oxide) and poly(acrylic acid) as release retardants. Eur J Pharm Biopharm. 2016;105:97–105.
   PubMed Web of Science ®Google Scholar
• Moodley K, Choonara YE, Kumar P, et al. In silico mechanistic disposition and in vivo evaluation of zero-order drug release from a novel triple-layered tablet matrix. Expert Opin Drug Deliv. 2015;12:1–21.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Gao B, Ma L, et al. Innovative intragastric ascaridole floating tablets: development, optimization, and in vitro-in vivo evaluation. Int J Pharm. 2015;496:432–439.
   PubMed Web of Science ®Google Scholar
• Gupta CR, Kishore GK, Ratna JV. Development and evaluation of aceclofenac matrix tablets using polyethylene oxides as sustained release polymers. J Pharm Res. 2013;6:249–254.
   Google Scholar
• Jia M, Li ZB, Chu HT, et al. Alginate-chitosan microspheres for controlled drug delivery of Diltiazem hydrochloride in cardiac diseases. J Biomater Tissue Eng. 2015;5(3):246–251.
   Web of Science ®Google Scholar
• Xie F, Ji S, Cheng Z. In vitro dissolution similarity factor (f2) and in vivo bioequivalence criteria, how and when do they match? Using a BCS class II drug as a simulation example. Eur J Pharm Sci. 2015;66:163–172.
   PubMed Web of Science ®Google Scholar
• Ferrero C, Jimenez-Castellanos MR. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate. Int J Pharm. 2014;461:270–279.
   PubMed Web of Science ®Google Scholar
• Körner A, Larsson A, Andersson A, et al. Swelling and polymer erosion for poly(ethylene oxide) tablets of different molecular weights polydispersities. J Pharm Sci. 2010;99:1225–1238.
   PubMed Web of Science ®Google Scholar
• Li H, Hardy RJ, Gu X. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets. AAPS PharmSciTech. 2008;9:437–443.
   PubMed Web of Science ®Google Scholar
• Tang X, Tai LY, Yang XG, et al. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions. Drug Dev Ind Pharm. 2013;39:67–76.
   PubMed Web of Science ®Google Scholar
• Díaz JEA, García-Montoya E, Pérez-Lozano P, et al. Contribution to the application in the Pharmaceutical Industry of the dissolution test for solid pharmaceutical forms. Gynecol Obstet Investig. 2006;17:719–738.
   Google Scholar
• Caccavo D, Cascone S, Lamberti G, et al. Controlled drug release from hydrogel-based matrices: experiments and modeling. Int J Pharm. 2015;486:144–152.
   PubMed Web of Science ®Google Scholar
• Ainurofiq A, Choiri S. Drug release model and kinetics of natural polymers-based sustained release tablet. Latin Am J Pharm. 2015;34:1328–1337.
   Web of Science ®Google Scholar
• Jayasree J, Sivaneswari S, Hemalatha G, et al. Role of various natural, synthetic and semi-synthetic polymers on drug release kinetics of losartan potassium oral controlled release tablets. Int J Pharm Investig. 2014;4:183–188.
   PubMedGoogle Scholar
• Choi dH, Lim JY, Shin S, et al. A novel experimental design method to optimize hydrophilic matrix formulations with drug release profiles and mechanical properties. J Pharm Sci. 2014;103:3083–3094.
   PubMed Web of Science ®Google Scholar
• Wang L, Chen K, Wen H, et al. Design and evaluation of hydrophilic matrix system containing polyethylene oxides for the zero-order controlled delivery of water-insoluble drugs. AAPS PharmSciTech. 2017;18:82.
   PubMed Web of Science ®Google Scholar
• Dimitrov M, Lambov N. Study of Verapamil hydrochloride release from compressed hydrophilic Polyox-Wsr tablets. Int J Pharm. 1999;189:105–111.
   PubMed Web of Science ®Google Scholar
• Gruberova L, Kratochvil B. Dissolution devices for simulation of in vivo conditions. Chemicke Listy. 2015;109:908–912.
   Web of Science ®Google Scholar
• Walsh PL, Bothe JR, Bhardwaj S, et al. A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets. Drug Dev Ind Pharm. 2016;42(5):836–844.
   PubMed Web of Science ®Google Scholar
• Maggi L, Segale L, Torre ML, et al. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study. Biomaterials. 2002;23:1113.
   PubMed Web of Science ®Google Scholar
• Piepho RW, Bloedow DC, Lacz JP, et al. Pharmacokinetics of diltiazem in selected animal species and human beings. Am J Cardiol. 1982;49:525–528.
   PubMed Web of Science ®Google Scholar
• Ferrebee CB, Dawson PA. Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids. Acta Pharm Sin B. 2015;5:129–134.
   PubMed Web of Science ®Google Scholar